Organizing Committee

iPharma 2017

Prof. Sinerik Ayrapetyan

UNESCO Chair-Life Sciences International
Postgraduate Educational Center

Prof. Sinerik Ayrapetyan has received his PhD in Cell Biophysics in the Institute of Physiology of Ukraine Academy of Sciences, Kiev during the period of 1966-1970. Currently, he is the coordinator of UNESCO Chair at Life Sciences International Postgraduate Educational Center, Yerevan, Armenia. He has successfully completed his Administrative responsibilities as the president of Life Sciences International Postgraduate Educational Center. His research has included the study of metabolic regulation of cell function in norm and pathology. He is serving as an editorial member of several reputed journals like “Electromagnetic Biology and Medicine”, “ISRN Biophysics”, “European Journal of Biophysics”, “Advances in Life Sciences", “Bioavailability and Bioequivalence”, “Applied Pharmacy”, “BBA General Subjects”, “International Dental and Medical Research", “International Journal of Basic and Applied Sciences” & expert Reviewer for journals like “Brain research”, “Radiobiology”, “Bioelectromagnetics”, “Journal of Alzheimer’s diseases”, “Life Sciences” etc. He has authored 7 international books and 115 research articles.

iPharma 2017

Prof. XU Baojun Bruce


Food Science and Technology

University of Illinois at Chicago


Prof. XU, Baojun Bruce is a Professor of Food Science and Technology department at University of Illinois at Chicago, USA.

His research interest includes 1) health benefits (targeted at aging, cancers, obesity, diabetes, and inflammatory diseases) assessment of phytochemicals from legumes, fruits, vegetables, traditional Chinese medicines through in vitro animal cell models; 2) cellular and molecular mechanisms of bioactive food components in disease prevention; 3) development of novel health promoting products and cosmeceuticals; 4) lab-scale and pilot scale extraction techniques of natural functional polysaccharides.

David W. Moskowitz-ipharma2017-ocm-genomed

David W. Moskowitz

CEO and Chief Medical Officer, GenoMed, Inc.


Well-trained nephrologist and founder, CEO, and Chief Medical Officer of GenoMed, a Next Generation DM(tm) company (DM = Disease Management). GenoMed is a patient-friendly company which does business over the Internet. It is the only player in healthcare to use cutting-edge, genomics-based medicine to lower healthcare costs. We are pioneers in preventive molecular medicine. We are revolutionizing healthcare--converting it from an anti-patient, increasingly expensive, largely futile, hospital-based industry to a patient-friendly, inexpensive, outpatient-based exercise in effective prevention of disease.

Huixiao Hong-iPharma2018

Dr. Huixiao Hong

Senior Scientist- NCTR

U.S. Food and Drug Administration


Huixiao Hong, Ph.D., is a senior Scientist at the Division of Systems Toxicology, National Center for Toxicological Research (NCTR), US Food and Drug Administration (FDA), Arkansas, USA, working on the scientific bases for regulatory application and development of genomics and biomarkers at the FDA. Before he joined the FDA, he was a senior Bioinformatician and the Manager of Bioinformatics Division at Z-Tech, an ICFI company. He held a Research Scientist position at Sumitomo Chemical Company in Japan. He was a visiting scientist at National Cancer Institute (NCI) at National Institutes of Health (NIH). He was also an Associated Professor and the Director of Laboratory of Computational Chemistry at Nanjing University in China. He published more than 80 scientific papers and served as an Executive Editor or a member of Editorial Board of 9 peer-reviewed journals and as a reviewer of more than 20 peer-reviewed journals in the area of pharmacogenomics, proteomics, bioinformatics, and chemoinformatics. He received his Ph.D. from Nanjing University in China and did post-doctoral research at Maxwell Institute in Leeds University in England.


Dr. Myra Lee Weiner

President, TOXpertise, LLC.

Dr. Weiner is widely known toxicologist with expertise on food additives and ingredients. During her thirty years as an corporate research toxicologist, her responsibilities included safety assessment of existing and new products; designing and directing toxicology studies; and interfacing with trade associations and regulatory agencies on a global basis. Her publications include over forty peer-reviewed articles on food additives, pharmaceutical excipients, industrial chemicals, drugs and pesticides. Dr. Weiner has participated in numerous international meetings and task forces. She co-edited Excipient Toxicity and Safety (Marcel Dekker, 1999), and was the recipient of the 2011 Marshall Steinberg Memorial Award from the International Pharmaceutical Excipients Council Foundation for outstanding contributions and achievements in excipient safety. She has been a Diplomate of the American Board of Toxicology for thirty years and a Fellow of the Academy of Toxicological Scientists for seven years. Dr. Weiner earned a B.A. in Biology cum laude from Stern College for Women; a Ph.D. in Pharmacology from Downstate Medical Center, the State University of New York, and completed a postdoctoral appointment at the Research Institute of Pharmaceutical Sciences, University of Mississippi. Currently, she is a consultant for her firm, TOXpertise, LLC.


Ye Xu

Jilin Medical University

Ye Xu is currently working in Jilin Medical University. He served on many institutional, national, and international committees and advisory boards. He has successfully organized and directed many scientific meetings and symposia and managed many multi-institutional and international collaborative research projects and programs. He has actively contributed to the scientific community through publication, meeting presentations, and lectures worldwide.

Website Designing Company Web Development Company India
move to top